Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Prostatic Neoplasms × Radiomics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2 Prostatic Neoplasms 1 Liver Cirrhosis 1 Hepatitis B 1 Endometrial Neoplasms 1 Disease Progression 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Docetaxel 18 Radiosurgery 17 Radiotherapy 14 Androgen Antagonists 14 Leuprolide 11 bicalutamide 9 Goserelin 9 enzalutamide 8 Surveys and Questionnaires 8 Radiotherapy, Intensity-Modulated 7 Prednisone 7 Blood Specimen Collection 7 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6 Gonadotropin-Releasing Hormone 6 Triptorelin Pamoate 5 Multiparametric Magnetic Resonance Imaging 5 Brachytherapy 5 Abiraterone Acetate 5 Standard of Care 4 Positron Emission Tomography Computed Tomography 4 Metformin 4 Heavy Ion Radiotherapy 4 Exercise 4 Estramustine 4 pembrolizumab 3 luprolide acetate gel depot 3 darolutamide 3 cabazitaxel 3 abiraterone 3 Watchful Waiting 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03979573 2019-06-07

PROMM-AS

Heinrich-Heine University, Duesseldorf

Phase NA Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡